Atlas Trials

Study of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's Disease

Clinical trial NCT01569516 · UNKNOWN

Trial details

NCT number
NCT01569516
Sponsor
Changchun Huayang High-tech Co., Ltd
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2011-06-01
Primary completion
2012-07-01
Enrollment
288

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.